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Summary
Background—Mechanical forces regulate cell behavior and function during development,
differentiation, and tissue morphogenesis. In the vascular system, forces produced by blood flow
are critical determinants not only of morphogenesis and function, but also pathological states such
as atherosclerosis. Endothelial cells (ECs) have numerous mechanotransducers, including platelet
endothelial cell adhesion molecule-1 (PECAM-1) at cell-cell junctions and integrins at cell-matrix
adhesions. However, the processes by which forces are transduced to biochemical signals and
subsequently translated into downstream effects are poorly understood.
Results—Here, we examine mechanochemical signaling in response to direct force application
on PECAM-1. We demonstrate that localized tensional forces on PECAM-1 result in, surprisingly,
global signaling responses. Specifically, force-dependent activation of phosphatidylinositol 3-
kinase (PI3K) downstream of PECAM-1 promotes cell-wide activation of integrins and the small
GTPase RhoA. These signaling events facilitate changes in cytoskeletal architecture, including
growth of focal adhesions and adaptive cytoskeletal stiffening.
Conclusions—Taken together, our work provides the first evidence of a global signaling event
in response to a localized mechanical stress. In addition, these data provide a possible mechanism
for the differential stiffness of vessels exposed to distinct hemodynamic force patterns in vivo.
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Mechanical forces are involved in nearly all aspects of biology [1]. Within the vascular
system, hemodynamic forces produced by blood flow play a critical role in EC biology and
maintenance of the vascular hemostasis. Cells respond to mechanical stresses on
mechanosensitive proteins, such as integrins, by employing an adaptive cellular stiffening
response in an effort to resist increased tensile strain [2-4]. Adaptive cellular stiffening
requires the coordination of mechanically activated signaling cascades, including the small
GTPase RhoA and its effectors, which mediate local changes in focal adhesion growth and
actomyosin contractility [3, 5, 6].
Within the vascular system, ECs lining the lumen of blood vessels are positioned to
experience constant force as a result of the shear stress of blood flow. Hemodynamic forces
influence EC biology and play an integral role in determining the health and integrity of the
vessel. To this regard, ECs are decorated with numerous mechanosensors that function to
convert mechanical forces into defined biochemical signaling cascades. We have previously
identified PECAM-1 as a key endothelial mechanosensor that influences vessel physiology
and pathology [7-9], yet insights into cellular responses directly linked to PECAM-1-
dependent force transduction are lacking.
Here, we use a magnetic tweezers system and permanent ceramic magnet to investigate
cellular responses to mechanical tension on PECAM-1. We reveal a mechanotransduction
pathway that involves integration of signaling between two mechanosensors at distinct
cellular sites. Specifically, force transduction via PECAM-1 promotes integrin-dependent
RhoA activation, leading to focal adhesion growth and adaptive cellular stiffening.
Furthermore, we provide evidence that local mechanical stimulation of PECAM-1 can
initiate a global cellular response, providing new insights into the spatial regulation of
mechanochemical signaling cascades.
Results
Tensional forces on PECAM-1 result in adaptive cellular stiffening and mechanosignaling
In order to investigate mechanoresponses downstream of PECAM-1, we applied tensional
forces, using magnetic tweezers [10], to paramagnetic beads bound to endogenous
PECAM-1 on ECs adherent on fibronectin (FN) (Fig. S1A). Brief force application
(~100pN) revealed a typical viscoelastic-creep response similar to those seen with bead-
integrin linkages [3] (Figure S1B). Application of successive pulsatile forces on PECAM-1
resulted in a significant decrease in pulse-to-pulse bead displacement in latter pulses,
indicative of force-dependent adaptive stiffening (Fig. 1A). Furthermore, average bead
displacement decreased approximately 40% by the end of the 2-minute time course,
indicating a 40% increase in cell stiffness with a calculated time constant of 39.93 seconds
(Fig. S1C). It is important to note that bead displacement decreased without significant
displacement of cellular organelles, such as the nucleus (Fig. S1D), and analysis of bead
recovery following each pulse of force revealed a 90-95% recovery from each pulse of force
(Fig. S1E), suggesting that baseline drift in bead recovery is negligible in the adaptive
response. Importantly, adaptive stiffening was specific to anti-PECAM-1-coated beads, as
force application to poly-lysine-coated beads did not initiate a mechanical response
(Supplementary Fig. S1F). Previous work demonstrated activation of PI3K downstream of
PECAM-1[7]. In order to examine PI3K activation in response to localized tensional forces
on PECAM-1, magnetic beads bound to ECs expressing a GFP-PH fusion protein (which
serves as a sensor for PI3-lipids) were subjected to force using a permanent ceramic magnet.
Brief force application was sufficient to induce PI3K activation around anti-PECAM-1-
coated beads (Fig. 1B). Recruitment around the bead was specific to PECAM-1 and not due
Collins et al. Page 2













to perturbation of the membrane, as ECs transfected with GFP alone (Fig. S1G) or ECs
incubated with poly-lysine-coated beads (Fig. S1H) did not display recruitment in response
to force. In order to examine if PI3K activation is required for adaptive cytoskeletal
stiffening, pharmacological inhibitors were used to block PI3K activation. Pretreatment of
ECs with PI3K inhibitors, LY294002 (Fig. 1C) and wortmannin (data not shown), or
inhibition of actin polymerization with Cytochalasin D (Fig. 1C), abolished adaptive
stiffening, suggesting a requirement for both biochemical signaling and cytoskeletal
remodeling. It is important to note that, in addition to an impaired response to mechanical
force on PECAM-1, cells pretreated with Cytochalasin D also exhibited a decrease in basal
cell stiffness, indicated by a significant increase in absolute bead displacement during the
first pulse of force (Fig. S1I).
PECAM-1-mediated adaptive stiffening is an integrin-dependent process
Growing evidence suggests that the integrin-extracellular matrix (ECM) adhesions function
as sites of mechanotransduction, where upon application of external forces on integrins, an
intracellular response is activated that leads to local focal adhesion assembly and associated
cytoskeletal strengthening [2, 4, 11]. We therefore examined if integrin ligation with the
underlying ECM plays a role in force transmission via PECAM-1. We used a blocking
(16G3) or nonblocking (11E5) antibody to inhibit new integrin-FN connections without
disrupting existing adhesions [12]. Inhibition of force-induced integrin engagement with the
FN blocking antibody attenuated PECAM-1-mediated adaptive stiffening, whereas the
nonblocking antibody had no effect (Fig. 2A). These data suggest that new integrin-FN
connections are required for adaptive stiffening, and indicate that the mechanical response
requires input from more than one mechanosensor. Next, we tested the possibility that new
integrin-FN connections are required for force-induced PI3K activation. To this regard,
inhibition of new integrin-FN connections had no effect on force-dependent PI3K activation
(Fig. 2B), as ECs subjected to force showed similar levels of activation in the presence of
the blocking and nonblocking antibodies. These data suggest that PI3K activation is
upstream of integrin ligation with the underlying ECM.
Tensional forces on PECAM-1 activate the RhoA pathway via GEF-H1 and LARG
Local activation of the small GTPase RhoA has been implicated in adaptive cellular
stiffening in response to mechanical stresses on integrins [3, 11]. To investigate the role of
the RhoA pathway in adaptive stiffening downstream of PECAM-1, ECs were pretreated
with C3 transferase or Y27632, Rho and ROCK inhibitors, respectively, prior to force
application. Inhibition of either Rho or ROCK attenuated adaptation to force (Fig. 3A),
suggesting a role for the RhoA pathway in adaptive stiffening. We therefore hypothesized
that tensional forces on PECAM-1 leads to RhoA activation, which is required for
cytoskeletal adaptation to force. To test this hypothesis, we performed Rho pulldown assays
to detect levels of active RhoA. ECs were incubated with anti-PECAM-1-and stimulated
with continuous force (~10pN) using a permanent magnet for biochemical analyses. Indeed,
ECs subjected to tensional force on PECAM-1 displayed robust and sustained RhoA
activation in response to force, as levels of GTP-loaded RhoA increased at 5 minutes of
force application and remained elevated at 30 minutes of sustained force (Fig. 3B). Force-
induced RhoA activation was specific to PECAM-1, as poly-lysine-coated beads did not
increase levels of active RhoA in response to force (Fig. S2). Interestingly, PECAM-1-
mediated RhoA activation was integrin-dependent, as inhibition of new integrin-FN
connections quenched force-induced RhoA activity (Fig. 3C).
We next sought to identify the guanine nucleotide exchange factors (GEFs) that mediate
force-induced RhoA activation by performing affinity pulldowns with a nucleotide-free
RhoA mutant (G17A) [13]. Analysis revealed a force-dependent increase in GEF-H1 and
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LARG activity, while the activity of other GEFs, such as Dbl, Vav, and Net1 were
unaffected (Fig. 4A). Interestingly, these GEFs also mediate RhoA activation in response to
tensional forces on FN-binding integrins [11]. It was also reported that mechanical
activation of GEF-H1 relies on activation of a FAK/ERK pathway. Previous studies have
demonstrated force-dependent activation of ERK downstream of PECAM-1 [14-16]. In
agreement with previous reports, in response to tensional forces on PECAM-1, we observed
a force-dependent increase ERK activation, as well as FAK phosphorylation (Fig. 4B).
Furthermore, inhibition of FAK or ERK activity with pharmacological inhibitors (FAK 14
or U0126, respectively), attenuated force-induced GEF-H1 activation, while LARG activity
was unaffected (Fig. 4C). These data suggest a common pathway employed for GEF
activation in response to tension on diverse adhesion molecules, and, therefore, may
represent a conserved mechanosensitive pathway. In order to confirm a role for GEF-H1 and
LARG in PECAM-1-mediated RhoA activation, siRNAs were used to knockdown these
GEFs in ECs. Depletion of GEF-H1 and LARG with specific siRNAs attenuated RhoA
activation and adaptive cellular stiffening in response to tensional forces on PECAM-1 (Fig.
4D,E), further supporting a role for these GEFs in PECAM-1-dependent stiffening.
Localized tensional forces on PECAM-1 a global mechanotransduction response
Our data suggest that force-induced RhoA activation downstream of PECAM-1 is integrin-
dependent (Fig. 3C). In order to assay integrin activation in response to tensional force on
PECAM-1, ECs were immunostained for ligated β1 integrin (Fig. 5A). Unexpectedly, we
observed a global increase in β1 integrin ligation, rather than a local response confined to the
region proximal to the bead under tension. This result was surprising, as previous studies
applying tensional forces on other adhesion receptors demonstrated a local cellular response
restricted to the site of mechanical stress [4]. Cells were assayed for the ratio of “global”
versus “local” integrin activation, where “local” was defined as the region with a 5 micron
radius from the site of bead attachment and the rest of the cell was deemed “global.” As seen
in Supplementary Figure S3, while total intensity of activated integrin staining increases
with force, the ratio of local to global integrin activation does not significantly change.
These data suggest that all areas of the cell can activate integrins to a similar level and
indicate that there is no preferential localization of integrin activation.
PI3K has been implicated in integrin activation in numerous cell types, including ECs in
response to shear stress. To this regard, pharmacological inhibition of PI3K attenuated
PECAM-1-mediated integrin ligation with the ECM (Fig. 5B), suggesting that PI3K
activation is required for global integrin activation. We hypothesized that soluble lipid
products produced by activated PI3K may promote cell-wide integrin activation. Previous
studies have employed the overexpression of a GFP-PH construct to sequester cellular
phospholipid messengers [17], as overexpression of GFP-PH restricts the mobility of
cellular lipid messengers and affects downstream signaling. In order to test the hypothesis
that mobility of PI3K lipid products is required for global integrin activation, we applied
force to PECAM-1 on ECs overexpressing GFP-PH and assayed integrin-ECM ligation.
Overexpression of the PH domain (which sequesters PI3K-mediated lipids) inhibited global
integrin activation (Fig. 5C). This effect was specific, as overexpression of GFP alone did
not affect force-induced β1 integrin activation. These data suggest that activation of PI3K
and production of a soluble second messenger promotes global integrin activation at sites
remote from the applied force.
In light of our data indicating global integrin activation in response to a localized force on
PECAM-1, we next tested if downstream RhoA activation was also a global response using
a RhoA biosensor that detects RhoA activation via fluorescence resonance energy transfer
(FRET) [18]. ECs transfected with the biosensor were subjected to force for the indicated
times and fixed for subsequent FRET analysis. Importantly, fixation did not significantly
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affect the FRET signal intensity or localization (Fig. S4A). Consistent with our biochemical
assays, we detected a statistically significant increase in RhoA activation after 5 minutes of
force (Fig.6A). A trend for increased RhoA activation remained at 30 minutes, but was no
longer significant, as 30% of the population had returned to basal levels by this time point.
These results are not surprising, as it has been demonstrated that, under chronic force, ECs
dampen activated signaling networks to maintain homeostasis. Importantly, a significant
increase in FRET was exclusive to anti-PECAM-1-coated beads, as poly-lysine-coated
beads did not display increased activation in response to force. In agreement with the ligated
β1 integrin immunostaining, ECs also displayed a remarkable cell-wide increase in RhoA
activity in response to force on PECAM-1 (Fig. 6A), as RhoA activity increased equally in
local and global regions of the cell (Fig. S4B). In contrast to PECAM-1, tensional forces on
FN-binding integrins did not induce global RhoA activation (data not shown).
Adaptive cellular stiffening is mediated, in part, by a local increase in focal adhesions at the
site of mechanical stress that function to resist the applied force [5, 19, 20]. To further
explore the possibility that localized force on PECAM-1 could lead to a global cellular
response, we assessed focal adhesion growth by immunostaining for the focal adhesion
marker vinculin. Remarkably, ECs exhibited a cell-wide increase in focal adhesion number,
as well as individual focal adhesion size in response to tensional forces on PECAM-1 (Fig.
6B). These results further support the notion that a local force on PECAM-1 promotes a
global signaling and cytoskeletal response.
Discussion
The present study provides insights into a mechanochemical signaling pathway downstream
of PECAM-1 that relies on signals from multiple inputs, including mechanosensors at other
transduction sites, such as integrins (Fig. 6C). We propose that force application on
PECAM-1 results in PI3K activation, which leads to global activation of integrins and
subsequent global RhoA activation via GEF-H1 and LARG. Activation of the GTPase
promotes changes in cytoskeletal organization, including adaptive stiffening of the
cytoskeleton and a cell-wide growth of focal adhesions. Using pharmacological inhibitors,
we show that numerous signaling molecules work in concert to facilitate adaptive cellular
stiffening. Interestingly, cells treated with cytoskeletal inhibitors (Cytochalasin D, C3, and
Y27632) are immediately impaired and cannot respond to force (pulses 2-11, Figs.1C, 3A),
whereas inhibition of new FN-integrin connections do not impair the mechanical response
until latter pulses (pulses 5-11, Fig. 2A). These data suggest that pre-existing tension within
the cytoskeleton is required for the immediate response to force, while new FN-integrins
interactions are required for strengthening of adhesions and adaptive stiffening. At the
present time it is difficult to determine if adaptive stiffening is a cell-wide phenomenon or a
local event that occurs proximal to the site of force application. However, a global increase
in focal adhesion size and number suggests that regions of the cell distal from the site of
mechanical stress are responsive to exogenous force.
Previous studies probing integrins reported rapid mechanosignaling propagated through
tensile cytoskeletal elements to remote cytoplasmic locations away from the site of
mechanical stress [21-23]. However, these signals were not global and diffuse, but rather
confined to distinct foci that corresponded with sites of cytoskeletal deformation. Thus, we
provide the first evidence of a global signaling event in response to a localized mechanical
stress.
While PECAM-1 has not been shown to directly interact with the cytoskeleton, indirect
association via cytoplasmic interactions with β-catenin and γ-catenin have been proposed
[21,24]. Although we cannot rule out that mechanical signaling through tensile cytoskeletal
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elements may contribute to PECAM-1-mediated mechanotransduction, our data suggest that
chemical signaling (via activated PI3K) is required for a global cellular response, such as
integrin activation. We also observed a delayed cellular stiffening response following force
application on PECAM-1 compared to the immediate stiffening response reported when
probing integrins [3, 11]. This delayed response further suggests involvement of a chemical
signaling component, as one would anticipate an exclusively mechanical response to occur
on a millisecond timescale. Future studies with PECAM-1 cytoplasmic tail truncation
mutants may provide insight into the relative contributions of mechanical and chemical
signaling components in adaptive stiffening.
Our study also highlights cooperation of two mechanosensors (PECAM-1 and integrins) in
the EC response to force. Previous studies have highlighted a complex relationship between
PECAM-1 and integrins. PECAM-1/PECAM-1 homophilic engagement can upregulate
function of β1 integrins in numerous cell types. Crosslinking of PECAM-1 on specific
subsets of T-lymphocytes increases β1-mediated adhesion [25]. In addition, engagement of
PECAM-1 on platelets increases integrin-dependent adhesion and aggregation [26]. Our data
suggest that PECAM-1-mediated mechanosensing may also promote β1-mediated adhesion
in ECs, as tension on PECAM-1 initiates β1 ligation with the underlying extracellular
matrix. Furthermore, β1 integrin engagement has also been shown to mediate tyrosine
dephosphorylation of the cytoplasmic tail of PECAM-1, which may influence PECAM-1-
mediated signaling [27]. Therefore, it is possible that a complex feedback loop may be
present in our system. Importantly, a complex relationship between PECAM-1 and αvβ3
also exists. αvβ3 serves as a heterotypic ligand for PECAM-1, and interaction between these
proteins may be important for endothelial functions such as leukocyte transendothelial
migration and angiogenesis [28]. While we focus on the β1 integrin subtype, αvβ3 integrins
may also contribute to the EC response to force. At the present time, we cannot differentiate
the contribution of the different FN-binding integrin subtypes to the cellular response to
tension on PECAM-1. However, previous studies have implicated a role for α5β1 clustering
in the formation of adhesions that experience strong matrix forces, while αvβ3 integrin
heterodimers strengthen integrin-cytoskeleton linkages in a talin-dependent manner [29].
Therefore, it is likely that multiple integrin subtypes may also be involved in PECAM-1-
mediated mechanotransduction.
Atomic force microscopy (AFM) studies have revealed that ECs in regions of the
vasculature that experience disturbed hemodynamics, and are thus predisposed to
development of atherosclerotic plaques, exhibit increased stiffness when compared to ECs in
healthy regions of the vessel [30]. Interestingly, regions of disturbed shear stress are also
rich in FN deposition [31, 32], which, we now show, promotes a stiffer cellular phenotype.
Therefore, our work may provide insights into early signaling events that contribute to
cellular stiffening and plaque development.
Experimental Procedures
Cell culture, reagents, and antibodies
Bovine aortic endothelial cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM, CellGro) with 10% fetal bovine serum, and 1% penicillin/streptomycin solution.
Cells were plated on fibronectin (10μg/ml) 4 hours prior to experiments. LY294002,
Cytochalasin D, wortmannin, and Y27632 were purchased from Calbiochem. Cell
permeable C3 transferase was purchased from Cytoskeleton. The PECAM-1 antibody
(PECAM 1.3) was a generous gift from D.K. Newman (BloodCenter of Wisconsin). Integrin
blocking (16G3) and nonblocking (11E5) antibodies were kindly provided by K. Yamada
(NIH). The LARG antibody was a generous gift from Kozo Kaibuchi (Nagoya University,
Japan). Antibodies to RhoA (26C4) and Dbl (sc-89) were purchased from Santa Cruz
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Biotechnologies. The GEF-H1 was from Cell Signaling and the antibody to Vav was from
BD Transduction. The antibody to Net1 was obtained from Abcam and the vinculin
antibody was purchased from Sigma. The HUTS-4 antibody (which recognizes ligated β1
integrin) was purchased from Millipore.
Transfections and RNA interference
For GFP-PH and FRET experiments, cells were seeded at 50% confluence and transfected
with 2.5μg of the GFP-PH construct or RhoA biosensor using Effectene reagents (Qiagen)
according to the manufacturer’s protocol and experiments were performed 48 hours after
transfection. For RNA interference experiments, control (Dharmacon siGLO RISC-free
control siRNA), GEF-H1, or LARG siRNAs (Dharmacon) were transfected into cells using
DharmaFECT4 (Dharmacon), according to the manufacturer’s instructions. Cells were
plated on FN 72 hours post-transfection and experiments were performed. The following
siRNA sequences were used in this study: GEF-H1: 5′-
AGACAGAGGAUGAGGCUUAUU-3′; and LARG: 5′-
GGGAAUAUGGAGAGAAUUAUU-3′.
Preparation of beads
Tosyl-activated paramagnetic beads (2.8 or 4.5 micron, Invitrogen) were washed with PBS
and coated with an anti-PECAM-1 antibody (PECAM 1.3) or poly-lysine solution (Sigma)
according to the manufacturer’s instructions. Beads were quenched in 0.2M Tris prior to use
to remove any remaining tosyl group and resuspended in DMEM containing 10% fetal
bovine serum and 1% penicillin/streptomycin solution. Immediately before experiments ECs
were incubated with beads (2-6 beads/cell) for 30 min at 37°C. Cells were briefly washed
with fresh media to remove unbound beads prior to force application.
Pulsatile force application
The UNC 3D Force Microscope (3DFM) was used to apply controlled pulsatile forces
(~100pN) to anti-PECAM-1-coated magnetic beads (2.8μm diameter). Bead displacements
were recorded with a high-speed video camera (Pulnix, JAI) and tracked using Video Spot
Tracker (Center for Computer Integrated Systems for Microscopy and Manipulation). Cells
were monitored for changes in morphology, movement of the nucleus, cell edges, and
particulates. No significant changes in cell morphology or movement of organelles were
noticeable.
Permanent force application
For all immunostaining and biochemical analyses, continuous force (~10pN) was applied to
anti-PECAM-1-coated beads (4.5μm diameter) using a permanent ceramic magnet (K&J
Magnetics) parallel to the culture dish surface at a distance of 1cm from the adherent cells.
No significant changes in cell morphology or movement of the nucleus, cell edges, or
organelles was noticeable.
Immunofluorescence
To examine activation of PI3K, GFP-PH-transfected cells subjected to force (permanent
magnet, 4.5μm beads) were fixed for 20 min in PBS containing 2% formaldehyde and
mounted in Vectashield mounting medium (Vector laboratories). For all other experiments,
cells were fixed for 20 min in PBS containing 2% formaldehyde, permeabilized with 0.2%
Triton X-100, and blocked with PBS containing 10% goat serum for 1hr at room
temperature. Antibody incubations were performed as previously described [33] and
mounted in Vectashield mounting medium. Images were acquired using a confocal
microscope (Olympus FV500) with a 63x oil lens.
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Adherent cells were incubated with anti-PECAM-1-coated beads (4.5 micron, Invitrogen)
for 30 min and subjected to force for indicated times. Active RhoA pulldowns were
performed as previously described[34]. Briefly, following force application, cells were lysed
in 50mM Tris (pH 7.6), 500mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate,
10mM MgCl2, and protease inhibitors. Anti-PECAM-1-coated magnetic beads were
removed from lysates with a magnetic separator. Lysates were centrifuged for 5min and
supernatants were transferred to a new tube and incubated at 4° with 80μg of purified (GST-
RBD) bound to glutathione-sepharose beads. Bead pellets were washed in 50mM Tris (pH
7.6), 150mM NaCl, 1% Triton X-100, 10mM MgCl2, and protease inhibitors, and
subsequently resuspended in Laemmli sample buffer and subjected to SDS-PAGE.
Precipitation of active GEFs with the nucleotide-free RhoA mutant (G17A) were performed
as previously described[13]. Briefly, following force application cells were lysed in 20mM
HEPES (pH 7.6), 150mM NaCl, 1% Triton X-100, 5mM MgCl2, and protease inhibitors.
Lysates were incubated at 4°C for 45 minutes with 100μg of purified GST-G17A RhoA
bound to glutathione-sepharose beads. Pelleted beads were then wash in lysis buffer,
resuspended in Laemmli sample buffer, and subjected to SDS-PAGE.
FRET analysis
RhoA activation was measured by FRET in fixed cells by monitoring the ratio of FRET
(ECFP excitation and Citrine emission) to ECFP emission (ECFP excitation and emission)
as previously described[18, 35]. Cells were chosen for similar, low expression levels.
Single-frame images were acquired on an inverted epifluorescence microscope (model
IX81; Olympus), using a 40X UPlan FLN 1.3 N/A DIC lens (Olympus), a CCD camera
(CoolSnapESII; Roper Industries), and MetaMorph software (Universal Imaging). For
emission ratio imaging, the following filter sets were used (Chroma Technology Corp.):
CFP: D436/20, D470/40; FRET: D436/20, HQ535/30; YFP: HQ500/20, HQ535/30. A
dichroic mirror was custom-manufactured by Chroma for compatibility with all of these
filters. Cells were illuminated with a 100 W Hg arc lamp through an ND 1.0 neutral density
filter. At each time point, three images were recorded with the following exposure times:
CFP (1.2 s) and FRET (0.6 s)
Metamorph software was used to perform image analysis. All images were first shading-
corrected and background-subtracted. The FRET image, because it had the largest signal-to-
noise ratio and therefore provided the best distinction between the cell and the background,
was thresholded to generate a binary mask with a value of zero outside the cell and a value
of one inside the cell. After multiplication by this mask, the FRET image was divided by the
CFP image to yield a ratio image reflecting RhoA activation throughout the cell. A linear
pseudocolour lookup table was applied, and the ratio values were normalized to the lower
scale value which was chosen to exclude the bottom 5% of the total histogram distribution,
thereby avoiding spurious low intensity pixels. In each experiment, all images were
inspected to verify that all portions used to create the ratio image had a sufficiently high
signal-to-noise ratio. We targeted at least 300 gray level values (12-bit dynamic range)
above background in the lowest intensity regions within the cell (S/n > 3). This was
especially important in thin parts of the cell where fluorescence was low. The ratio was
corrected for bleaching using a method described elsewhere [35].
Whole-Cell FRET Analysis
To calculate whole-cell average FRET ratio for the determination of the effects of
mechanical force on RhoA activation, FRET ratio (FRET/CFP) images acquired and
processed as described above were loaded into Metamorph, thresholded to generate masks
for each cell, and regions were drawn around each cell using the mask. From these regions, a
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number of parameters, including average pixel intensity, could be measured and recorded.
Average FRET ratio intensity was calculated for each image for at least 10 cells per
condition and averaged for each treatment condition.
Quantification of integrin activation and focal adhesions
ECs stained for ligated β1 integrin- or vinculin were analyzed with NIH ImageJ software.
Confocal image planes at the basal surface of the cell were chosen for analysis and RGB
images were converted to 8-bit black and white images. Activated integrins and focal
adhesions were defined by setting an intensity threshold to remove any background signal.
Integrin activation and focal adhesion size and number were analyzed using the ‘Analyze
particles’ function.
Statistical analysis
Data are presented as means ± s.e.m. p-values were determined using a two-tailed unpaired
Student’s t-test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Tension on PECAM-1 results in adaptive cellular stiffening and
mechanosignaling
• PECAM-1-mediated mechanosensing requires activation of integrins
• Tensional forces on PECAM-1 stimulate integrin-dependent RhoA activation
• Localized tensional forces on PECAM-1 elicit a global mechanoresponse
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Figure 1. Tensional forces on PECAM-1 result in adaptive cellular stiffening and PI3-kinase
activation
(A) Schematic of experimental design. Two-second pulses of force (~100 pN) separated by
10-second intervals over a 2-minute time course. Representative example of bead
displacement in response to the pulsatile force regimen. Stiffening is indicated by decreased
displacement during latter pulses. (B) ECs expressing GFP-PH were incubated with anti-
PECAM-1-coated magnetic beads and subjected to force with a permanent ceramic magnet
for the indicated times. Cells were fixed and scored for GFP-PH recruitment around the bead
(box). Location of the bead is highlighted by the yellow circle (n > 50 cells/condition from 3
independent experiments; scale bar = 10μm). (C) Average relative anti-PECAM-1 bead
displacements induced by the pulsatile force regimen. In some experiments, cells were
pretreated with LY294002 (30μM for 20 min) or Cytochalasin D (10μM for 30 min) prior to
incubation with magnetic beads. Average displacements were calculated relative to the first
pulse of force. (n >15 beads/condition from 3 independent experiments). Error bars
represent s.e.m., *p<0.05. (See also Fig. S1)
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Figure 2. PECAM-1-mediated adaptive cellular stiffening, but not PI3K activation, is integrin-
dependent
(A) ECs were incubated with 20μg/ml of FN blocking (16G3) or nonblocking antibody
(11E5) for 20 min prior to force application. Average displacements were calculated relative
to the first pulse of force to anti-PECAM-1-coated beads (n > 15 beads/condition from 3
independent experiments) (B) ECs expressing GFP-PH were incubated with 16G3 or 11E5
(20μg/ml, 20min) antibodies prior to being subjected to force with a permanent ceramic
magnet. Cells were fixed and scored for GFP-PH recruitment around the bead (n > 50 cells/
condition from 3 independent experiments; scale bar = 10μm). Error bars represent s.e.m.,
*p<0.05.
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Figure 3. Tensional forces on PECAM-1 activate the RhoA pathway
(A) Adherent ECs were incubated with anti-PECAM-1-coated magnetic beads and subjected
to pulsatile tensional forces. For some conditions, cells were pretreated with C3 (2.0μg/ml,
2hrs) or Y27632 (5μM, 10min) prior to force application. Average displacements were
calculated relative to the first pulse of force. (n>15 cells/condition from 3 independent
experiments). Error bars represent s.e.m., *p<0.05. (B-C) ECs were incubated with anti-
PECAM-1-coated beads and subjected to force with a permanent ceramic magnet for the
indicted times (B) Active RhoA (RhoA-GTP) was isolated with GST-RBD and analyzed by
western blot (n=5). (C) ECs were incubated with 20μg/ml of FN blocking (16G3) or
nonblocking antibody (11E5) for 20 min prior to force application. Active RhoA (RhoA-
GTP) was isolated with GST-RBD and analyzed by western blot (n=3). Blots (B, C) are
representative of at least 3 independent experiments. (See also Fig. S2)
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Figure 4. Tensional forces on PECAM-1 elicit RhoA activation and adaptive cellular stiffening
via GEF-H1 and LARG
(A-D) Tension was applied to anti-PECAM-1-coated beads using a permanent ceramic
magnet for the indicated times, and (A) cells were lysed and active GEFs were precipitated
with GST-(G17A)RhoA and analyzed by western blot (n=3), (B) Cells were lysed, subjected
to SDS-PAGE, and immunoblotted with indicated antibodies. Blots are indicative of 3
independent experiments. (C) Cells were lysed and active GEFs were precipitated with
GST-(G17A)RhoA and analyzed by Western blot (n=3). For some conditions, cells were
pretreated with FAK inhibitor 14 (5μM, 30min) or U0126 (5μM, 30min) to inhibit FAK and
ERK, respectively (n=3). (D,E) siRNA-transfected ECs were incubated with anti-
PECAM-1-coated beads and subjected to force for the indicated times. Active RhoA was
isolated with GST-RBD and analyzed by western blot (n=3). All blots (A-D) are indicative
of at least 3 independent experiments. (E) siRNA-transfected ECs on FN were incubated
with anti-PECAM-1-coated beads and subjected to pulsatile forces. Average displacements
were calculated relative to the first pulse of force (n >15 beads/condition from 3 independent
experiments, *p<0.05).
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Figure 5. Local tensional forces on PECAM-1 elicit global β1 integrin activation
(A) ECs were incubated with anti-PECAM-1-coated beads (4.5μm) and subjected to force
with a permanent ceramic magnet for the indicated times. ECs were fixed and stained with
HUTS-4, which recognizes ligated β1 integrin, and phalloidin to mark the actin
cytoskeleton. (n > 30 cells/condition from 3 independent experiments; scale bar = 10μm,
*p<0.05, **p<0.02). (B) ECs were incubated with anti-PECAM-1-coated beads (4.5μm) and
subjected to force for the indicated times. ECs were fixed and stained for activated β1
integrins and the actin cytoskeleton. Cells were pretreated with LY294002 (30μM, 20min)
to inhibit PI3K activation prior to force application (n > 25 cells/condition from 3
independent experiments; scale bar = 10μm, *p<0.05). (C) ECs overexpressing GFP or
GFP-PH were incubated with anti-PECAM-1-coated beads (4.5μm) and force was applied.
ECs were fixed and stained for activated β1 integrins (n > 25 cells/condition from 3
independent experiments, *p<0.05). For all panels, integrin activation was quantified using
thresholded images and ImageJ software. Values were normalized to the “No Force”
condition. Error bars represent s.e.m. (See also Fig. S3)
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Figure 6. Local tensional forces on PECAM-1 elicit global RhoA activation and focal adhesion
growth
(A) ECs expressing the RhoA biosensor were incubated with poly-lysine or anti-PECAM-1-
coated beads (4.5μm) and subjected to force with a permanent ceramic magnet for the
indicated times. Cells were fixed and analyzed for FRET. Whole cell FRET ratios were
calculated for each condition. Autofluorescent beads are highlighted in black dotted circles
(n > 45 cells/condition from 4 independent experiments, *p < 0.05). (B) Adherent ECs on
FN were incubated with anti-PECAM-1-coated magnetic beads and subjected to force for
the indicated times. ECs were fixed stained with phalloidin and an anti-vinculin antibody to
mark focal adhesions. Focal adhesion number and size were quantified using NIH ImageJ
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software. Values were normalized to the “No Force” condition. Location of the beads are
highlighted in yellow circles (n > 30cells/condition from 3 independent experiments, *p <
0.05, scale bar = 10μm). (C) Model of PECAM-1-mediated mechanotransduction. Local
tensional forces on PECAM-1 results in global mechanosignaling and changes in
cytoskeletal architecture. (See also Fig. S4)
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